A Medicare beneficiary’s ability to have options and to make financially informed choices about his or her health care is essential. Advanced Beneficiary Notices of Non-Coverage (ABNs) play an important role in making sure beneficiaries understand their financial responsibilities for medical items and services that Original Medicare (i.e., fee-for-service) is expected to deny.
David Traskey recently secured a fully favorable decision in a client’s skin substitute case at hearing before an Administrative Law Judge.
Health Care IT contracts are rarely just about technology. They govern access to patient data, compliance with complex regulatory obligations, and the systems that keep day-to-day operations running. Yet these agreements are often dense, highly technical, and drafted on vendor-friendly terms, making it easy for critical risks to go unnoticed until something goes wrong.
A trailblazing decision has been issued by Judge Rakoff of the United States Federal Court for the Southern District of New York. The decision, issued on February 17, 2026, analyzes the applicability of attorney-client privilege and the work product doctrine to third-party generative Artificial Intelligence (AI) platforms.
The COVID-19 public health emergency resulted in widespread changes in the delivery of health care items and services to patients, particularly those that required “direct supervision” under Medicare Part B. The Centers for Medicare & Medicaid Services relaxed the direct supervision requirement during the PHE to include circumstances where a physician (or other practitioner) was “immediately available” by virtual presence through two-way audio/video real-time communications technology. Effective January 1, 2026, CMS adopted this relaxed definition of direct supervision permanently for a broad category of services.